Uniprim
Loading...Uniprim Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
Do not use in horses intended for human consumption.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
Trimethoprim/sulfadiazine is indicated in horses where potent systemic antibacterial action against sensitive organisms is required. Trimethoprim/sulfadiazine is indicated where control of bacterial infections is required during treatment of:
| Acute Strangles | Acute Urogenital Infections |
| Respiratory Tract Infections | Wound Infections and Abscesses |
Trimethoprim/sulfadiazine is well tolerated by foals.
History
There is currently no drug history available for this drug.
Other Information
UNIPRIM Powder contains 67 mg trimethoprim and 333 mg sulfadiazine per gram.
UNIPRIM Powder is a combination of trimethoprim and sulfadiazine in the ratio of 1 part to 5 parts by weight, which provides effective antibacterial activity against a wide range of bacterial infections in animals.
Trimethoprim is 2,4 diamino-5-(3, 4, 5-trimethoxybenzyl) pyrimidine.
Sources
Uniprim Manufacturers
-
Macleod Pharmaceuticals Inc.
![Uniprim Powder For Horses (Trimethoprim And Sulfadiazine) Powder [Macleod Pharmaceuticals Inc.]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Uniprim | Macleod Pharmaceuticals Inc.
The recommended dose is 3.75 g UNIPRIM Powder per 110 lbs (50 kg) body weight per day. Administer UNIPRIM Powder orally once a day in a small amount of palatable feed.
Dose Instructions: One 37.5 g packet is sufficient to treat 1100 lbs (500 kg) of body weight. For the 1125 g packets and 12 kg boxes, a level, loose-filled, 67 cc scoop contains 37.5 g, sufficient to treat 1100 lbs (500 kg) of body weight. For the 200 g, 400 g, and 1200 g jars, and 2000 g pail, two level, loose-filled, 32 cc scoops contain 37.5 g, sufficient to treat 1100 lbs (500 kg) of body weight. Since product may settle, gentle agitation during scooping is recommended.
The usual course of treatment is a single, daily dose for 5 to 7 days.
Continue acute infection therapy for 2 or 3 days after clinical signs have subsided.
If no improvement of acute infections is seen in 3 to 5 days, reevaluate the diagnosis.
UNIPRIM Powder may be used alone or in conjunction with intravenous dosing. Following treatment with trimethoprim/sulfadiazine 48% injection, therapy can be maintained using oral Powder.
A complete blood count should be done periodically in patients receiving UNIPRIM Powder for prolonged periods. If significant reduction in the count of any formed blood element is noted, treatment with UNIPRIM Powder should be discontinued.
-
Macleod Pharmaceuticals Inc.
Uniprim | Macleod Pharmaceuticals Inc.
The recommended dose is 3.75 g UNIPRIM Powder per 110 lbs (50 kg) body weight per day. Administer UNIPRIM Powder orally once a day in a small amount of palatable feed.
Dose Instructions: One 37.5 g packet is sufficient to treat 1100 lbs (500 kg) of body weight. For the 1125 g packets and 12 kg boxes, a level, loose-filled, 67 cc scoop contains 37.5 g, sufficient to treat 1100 lbs (500 kg) of body weight. For the 200 g, 400 g, and 1200 g jars, and 2000 g pail, two level, loose-filled, 32 cc scoops contain 37.5 g, sufficient to treat 1100 lbs (500 kg) of body weight. Since product may settle, gentle agitation during scooping is recommended.
The usual course of treatment is a single, daily dose for 5 to 7 days.Continue acute infection therapy for 2 or 3 days after clinical signs have subsided.
If no improvement of acute infections is seen in 3 to 5 days, reevaluate the diagnosis.
UNIPRIM Powder may be used alone or in conjunction with intravenous dosing. Following treatment with trimethoprim/sulfadiazine 48% injection, therapy can be maintained using oral Powder.
A complete blood count should be done periodically in patients receiving UNIPRIM Powder for prolonged periods. If significant reduction in the count of any formed blood element is noted, treatment with UNIPRIM Powder should be discontinued.
![Uniprim (Trimethoprim And Sulfadiazine) Powder [Macleod Pharmaceuticals Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=f853bc22-477d-4391-a80f-92a3c1c8f448&name=new_apple_pdp_400.jpg)
Login To Your Free Account